Mounjaro has superior persistence compared to Ozempic, especially when indicated to treat type II diabetes, according to Earnest pharmacy claims data
Plus on the metabolic side, weve seen very pronounced metabolic effects specifically related to this combination like loss in visceral adipose tissue and associated insulin resistance, improvements in inflammatory markers like C-reactive protein, all pointing in a positive direction that will ultimately improve clinical outcomes
These drugs, like GLP-1 agonists, aim to decrease food intake and improve blood glucose regulation
The primary difference is cost ($149/month versus $1,000+/month for brand Ozempic) and customization options through genetic testing and personalized protocols
Produkt oferowany przez Peptology to odczynnik research-grade , nieprzeznaczony do diagnozowania ani leczenia jakichkolwiek schorze skry czy tkanek